• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺癌腺泡伴导管及黏液腺癌合并肺转移:1例报告及文献复习

Acinar with ductal and mucinous adenocarcinoma of prostate cancer complicated with lung metastasis: a case report and literature review.

作者信息

Cui Yankang, Miao Chenkui, Xu Aiming, Wang Zengjun, Liu Bianjiang

机构信息

Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.

出版信息

Ann Palliat Med. 2021 Feb;10(2):2366-2370. doi: 10.21037/apm-20-386. Epub 2020 Jun 23.

DOI:10.21037/apm-20-386
PMID:32576002
Abstract

Acinar adenocarcinoma, ductal adenocarcinoma and mucinous adenocarcinoma are the subtypes of prostate cancer (PCa). Most of the pathological types of PCa are acinar adenocarcinoma, while ductal adenocarcinoma and mucinous adenocarcinoma are uncommon. The case of acinar adenocarcinoma with ductal and mucinous adenocarcinoma has not been reported before. Herein, we report a treatment experience involving a 72-year-old man who presented similarly as most PCa patients, but the pathologic diagnosis was acinar adenocarcinoma with focal ductal and mucinous adenocarcinoma differentiating. Besides, this case is associated with lung metastasis, after radical prostatectomy (RP) and endocrine therapy the pulmonary nodule exerted a shrinking trend and the PSA level of this patient is still maintained at 0 ng/ mL till now. Through literature review, we found that patients who diagnosed as mixed pathological type of PCa had a lower survivor than pure PCa patients. Furthermore, there is no corresponding consensus or guideline for treating such multiple differentiated PCa patients. Surprisingly, this patient showed a high sensitivity to androgen deprivation therapy (ADT). Although the tumor presented aggressiveness, the followup results were satisfactory and we will continue to pay attention to his physical condition. We report this case to provide a treatment strategy for the patients with multi-differentiated PCa complicated with organ metastases.

摘要

腺泡腺癌、导管腺癌和黏液腺癌是前列腺癌(PCa)的亚型。PCa的病理类型大多为腺泡腺癌,而导管腺癌和黏液腺癌并不常见。此前尚未有腺泡腺癌合并导管和黏液腺癌的病例报道。在此,我们报告一例72岁男性的治疗经历,该患者临床表现与大多数PCa患者相似,但病理诊断为腺泡腺癌伴局灶性导管和黏液腺癌分化。此外,该病例伴有肺转移,在根治性前列腺切除术(RP)和内分泌治疗后,肺结节呈缩小趋势,该患者的前列腺特异性抗原(PSA)水平至今仍维持在0 ng/mL。通过文献回顾,我们发现诊断为PCa混合病理类型的患者生存率低于单纯PCa患者。此外,对于治疗这类多分化PCa患者尚无相应的共识或指南。令人惊讶的是,该患者对雄激素剥夺治疗(ADT)表现出高敏感性。尽管肿瘤具有侵袭性,但随访结果令人满意,我们将继续关注他的身体状况。我们报告此病例,旨在为多分化PCa合并器官转移的患者提供一种治疗策略。

相似文献

1
Acinar with ductal and mucinous adenocarcinoma of prostate cancer complicated with lung metastasis: a case report and literature review.前列腺癌腺泡伴导管及黏液腺癌合并肺转移:1例报告及文献复习
Ann Palliat Med. 2021 Feb;10(2):2366-2370. doi: 10.21037/apm-20-386. Epub 2020 Jun 23.
2
Optimal PSA Threshold for Androgen-Deprivation Therapy in Patients with Prostate Cancer following Radical Prostatectomy and Adjuvant Radiation Therapy.根治性前列腺切除术和辅助放疗后前列腺癌患者接受雄激素剥夺治疗的最佳 PSA 阈值。
Yonsei Med J. 2020 Aug;61(8):652-659. doi: 10.3349/ymj.2020.61.8.652.
3
Prognosis of mucinous adenocarcinoma of the prostate treated by radical prostatectomy: a study of 47 cases.根治性前列腺切除术治疗前列腺黏液腺癌的预后:47例病例研究
Am J Surg Pathol. 2008 Mar;32(3):468-72. doi: 10.1097/PAS.0b013e3181589f72.
4
Mucinous adenocarcinoma of prostate and prostatic adenocarcinoma with mucinous components: a clinicopathological analysis of 143 cases.前列腺黏液腺癌和伴有黏液成分的前列腺腺癌:143 例临床病理分析。
Histopathology. 2017 Oct;71(4):641-647. doi: 10.1111/his.13278. Epub 2017 Jul 19.
5
Transformation of prostatic adenocarcinoma to well-differentiated neuroendocrine tumor after hormonal treatment.激素治疗后前列腺腺癌转化为高分化神经内分泌肿瘤。
Hum Pathol. 2017 Jun;64:186-190. doi: 10.1016/j.humpath.2017.01.006. Epub 2017 Jan 31.
6
Solitary lung metastasis after radical prostatectomy in presence of undetectable PSA.前列腺癌根治术后出现孤立性肺转移且前列腺特异性抗原检测不到
Arch Ital Urol Androl. 2012 Dec;84(4):208-10.
7
[Clinical characteristics of prostatic adenocarcinoma with ductal features].[具有导管特征的前列腺腺癌的临床特征]
Nihon Hinyokika Gakkai Zasshi. 2008 Mar;99(3):525-30. doi: 10.5980/jpnjurol1989.99.525.
8
[Mucinous adenocarcinoma of the prostate. A case report and analysis of the literature].[前列腺黏液腺癌。1例病例报告及文献分析]
Nihon Hinyokika Gakkai Zasshi. 1994 Aug;85(8):1276-9. doi: 10.5980/jpnjurol1989.85.1276.
9
The prostatic adenocarcinoma with mucinous features: A review of the literature with three case reports.具有黏液特征的前列腺腺癌:文献复习并附三例报告。
J Cancer Res Ther. 2021 Apr-Jun;17(2):596-598. doi: 10.4103/jcrt.JCRT_673_18.
10
Use of Concomitant Androgen Deprivation Therapy in Patients Treated with Early Salvage Radiotherapy for Biochemical Recurrence After Radical Prostatectomy: Long-term Results from a Large, Multi-institutional Series.早期挽救性放疗后生化复发的前列腺癌患者应用同期雄激素剥夺治疗:一项大型多机构系列研究的长期结果。
Eur Urol. 2018 Apr;73(4):512-518. doi: 10.1016/j.eururo.2017.11.020. Epub 2017 Dec 8.

引用本文的文献

1
Prostate Cancer Lung Metastasis: Clinical Insights and Therapeutic Strategies.前列腺癌肺转移:临床见解与治疗策略
Cancers (Basel). 2024 May 30;16(11):2080. doi: 10.3390/cancers16112080.
2
LncFALEC recruits ART5/PARP1 and promotes castration-resistant prostate cancer through enhancing PARP1-meditated self PARylation.长非编码 RNA FALEC 通过募集 ART5/PARP1 并促进 PARP1 介导的自身 PAR 化来促进去势抵抗性前列腺癌的发生。
Cell Oncol (Dordr). 2023 Jun;46(3):761-776. doi: 10.1007/s13402-023-00783-z. Epub 2023 Mar 13.
3
Ductal adenocarcinoma of the prostate or seminal vesicle adenocarcinoma: An multi-disciplinary team (MDT) case report and literature review.
前列腺导管腺癌或精囊腺癌:多学科团队(MDT)病例报告及文献综述
Curr Urol. 2022 Jun;16(2):107-113. doi: 10.1097/CU9.0000000000000084. Epub 2022 Feb 18.